Standard BioTools Inc. (NASDAQ:LAB – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 31st, there was short interest totalling 2,780,000 shares, a decline of 12.0% from the May 15th total of 3,160,000 shares. Currently, 3.7% of the company’s shares are sold short. Based […]
Standard BioTools Inc. (NASDAQ:LAB – Get Rating) CFO Jeffrey G. Black bought 43,492 shares of the firm’s stock in a transaction dated Thursday, May 18th. The shares were bought at an average price of $2.22 per share, with a total value of $96,552.24. Following the completion of the transaction, the chief financial officer now directly […]